Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF565 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | SALL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | RP11-15H20.8 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | DRAP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | FAM69B | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | ZNF853 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | PCDHAC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | RP11-795F19.5 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | ZMYM3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | PTP4A3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |